lacosamide
UkraineDrugs containing this active substance
-
The drug is used as adjunctive therapy for the treatment of partial seizures (with or without secondary generalization) in patients aged 16 years and older with epilepsy.
Form: tablets, film-coated
Active substance Dosage lacosamide 200 mg ATC: N03AX18
Manufacturer: Dzhenefarm SA (manufacturing, primary and secondary packaging, quality control and batch release of medicinal product)
-
The drug is indicated as adjunctive therapy for the treatment of partial seizures in patients aged 16 years and older with epilepsy.
Form: tablets, film-coated
Active substance Dosage lacosamide 50 mg ATC: N03AX18
Manufacturer: USF Pharma S.A. (manufacturer of unpackaged products and quality control)
-
The drug is used as adjunctive therapy for the treatment of partial seizures in patients aged 16 years and older with epilepsy.
Form: tablets, film-coated
Active substance Dosage lacosamide 100 mg ATC: N03AX18
Manufacturer: USF Pharma S.A. (manufacturer of unpackaged products and quality control)
-
The drug is used as adjunctive therapy for the treatment of partial seizures in patients aged 16 years and older with epilepsy.
Form: tablets, film-coated
Active substance Dosage lacosamide 150 mg ATC: N03AX18
Manufacturer: USF Pharma S.A. (manufacturer of unpackaged products and quality control)
-
The drug is used as adjunctive therapy for the treatment of partial seizures in patients aged 16 years and older with epilepsy.
Form: tablets, film-coated
Active substance Dosage lacosamide 200 mg ATC: N03AX18
Manufacturer: USF Pharma S.A. (manufacturer of unpackaged products and quality control)